Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients

Genetic and molecular studies indicate that dysbindin-1 plays a role in the pathophysiology of schizophrenia. We examined dysbindin-1 mRNA in the hippocampal formation of patients with schizophrenia and found reduced expression in dentate granule and polymorph cells and in hippocampal field CA3, but not in CA1. Furthermore, there were positive correlations between dysbindin-1 mRNA and expression of synaptic markers known to be reduced in schizophrenia. Our results indicate that previously reported dysbindin-1 protein reductions may be due in part to decreased dysbindin-1 mRNA and that reduced dysbindin-1 may contribute to hippocampal formation synaptic pathology in schizophrenia.

[1]  Paul J. Harrison,et al.  Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study , 1994, Neuroscience.

[2]  Paul J. Harrison,et al.  Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia , 2001, Hippocampus.

[3]  Takahisa Taguchi,et al.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.

[4]  Paul J. Harrison,et al.  Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[5]  Raquel E Gur,et al.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. , 2004, The Journal of clinical investigation.

[6]  Paul J. Harrison,et al.  Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. , 2004, The American journal of psychiatry.

[7]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[8]  Brien Riley,et al.  Molecular genetic studies of schizophrenia , 2006, European Journal of Human Genetics.

[9]  J. Kleinman,et al.  Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia , 2001, Schizophrenia Research.

[10]  B. Lipska,et al.  Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus , 2006, Journal of Neural Transmission.

[11]  Paul J. Harrison.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications , 2004, Psychopharmacology.

[12]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[13]  Chang-Gyu Hahn,et al.  Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. , 2006, Human molecular genetics.

[14]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[15]  Michael C O'Donovan,et al.  Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. , 2005, Human molecular genetics.

[16]  Daniel R Weinberger,et al.  Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. , 2004, Archives of general psychiatry.